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ABSTRACT	
Background:		
Cardiopulmonary	exercise	testing	(CPET)	is	increasingly	used	in	the	pre-operative	assessment	of	
patients	undergoing	major	surgery.	The	objective	of	this	study	was	to	investigate	whether	CPET	can	
identify	patients	at	risk	of	reduced	survival	following	abdominal	aortic	aneurysm	(AAA)	repair.	
Methods:		
Prospectively	collected	data	from	consecutive	patients	who	underwent	CPET	prior	to	elective	open	
or	endovascular	(EVAR)	AAA	repair	at	two	tertiary	vascular	centres	between	January-2007	and	
October-2012	were	analysed.	A	symptom	limited	maximal	CPET	was	performed	on	each	patient.	
Multivariable	Cox	Proportional	Hazards	regression	modelling	was	used	to	identify	risk	factors	
associated	with	reduced	survival.			
Results:		
The	study	included	506	patients	with	a	mean	age	of	73.4	(range	44-90).	The	majority	(82.6%)	were	
men	and	most	(64.6%)	underwent	EVAR.	The	in-hospital	mortality	was	2.6%.	Median	follow-up	was	
26-months.	The	three-year	survival	for	patients	with	zero	or	one	sub-threshold	CPET	value	(V! O2	at	
AT<10.2	ml	kg-1	min-1,	Peak	V! O2	<15	ml	kg-1	min-1	or	V! E/	V! CO2	at	AT>42)	was	86.4%	compared	to	
59.9%	for	patients	with	three	sub-threshold	CPET	values.	Risk	factors	independently	associated	with	
survival	were	female	gender	(HR=0.44,	95%CI	0.22-0.85,P=0.015),	diabetes	(HR=1.95,	95%CI	1.04-
3.69,P=0.039),	pre-operative	statins	(HR=0.58,	95%CI	0.38-0.90,	P=0.016)	haemoglobin	g	dl-1	
(HR=0.84,	95%CI	0.74-0.95,P=0.006),	peak	V! O2<15	ml	kg-1	min-1	(HR=1.63,	95%CI	1.01-2.63,P=0.046)	
and	V! E/	V! CO2	at	AT>42	(HR=1.68,	95%CI	1.00-2.80,P=0.049).	
Conclusions:		
CPET	variables	are	independent	predictors	of	reduced	survival	following	elective	AAA	repair	and	can	
identify	a	cohort	of	patients	with	reduced	survival	at	three	years	post	procedure.	CPET	is	a	
potentially	useful	adjunct	for	clinical	decision	making	in	patients	with	AAA.	
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INTRODUCTION	
Accurately	assessing	perioperative	risk	and	predicting	longer	term	clinical	outcomes	are	essential	in	
elective	abdominal	aortic	aneurysm	(AAA)	repair	as	for	most	patients	it	is	a	purely	prophylactic	
procedure.	A	number	of	different	methods	of	assessing	perioperative	risk	have	been	proposed	in	
patients	undergoing	AAA	repair	including	risk	prediction	models,1	biomarkers,2	assessment	of	
functional	capacity3	and	genetic	testing.4	Recent	guidelines	have	emphasised	that	when	indicated	a	
pre-operative	assessment	of	a	patients	functional	capacity	should	be	performed	for	patients	
undergoing	major	vascular	surgery.5-8		
Cardiopulmonary	exercise	testing	(CPET)	provides	a	gold	standard	assessment	of	functional	capacity.		
It	has	been	used	in	elite	sport	performance	and	research	for	some	time	and	is	now	increasingly	
utilised	in	the	pre-operative	assessment	of	patients	prior	to	major	non	cardiac	surgery.	The	ability	of	
CPET	to	identify	patients	who	are	at	an	increased	risk	of	adverse	peri-operative	outcomes	has	been	
assessed	in	a	variety	of	settings.9	10		
The	evidence	for	its	role	in	risk	stratifying	patients	undergoing	abdominal	aortic	aneurysm	(AAA)	
repair	has	so	far	been	limited	to	a	number	of	small	single-centre	studies.3	11-13	As	a	result	of	this	
there	is	uncertainty	about	its	usefulness	in	the	pre-operative	assessment	of	patients	with	AAA.	A	
recent	systematic	review	called	for	more	research	into	its	role	in	the	pre-operative	assessment	of	
patients	undergoing	vascular	surgery.14		
A	previous	study	by	our	group	has	demonstrated	that	variables	derived	from	CPET	were	
independent	predictors	of	30	and	90-day	mortality	following	elective	AAA	repair.15	Whilst	short-term	
outcomes	are	clearly	important	for	both	patients	and	clinicians,	better	understanding	of	the	risks	of	
mid-term	adverse	outcomes	is	important	for	clinical	decision	making.	The	objective	of	this	study	was	
therefore	to	investigate	whether	pre-operative	CPET	derived	variables	are	predictors	of	survival	
following	elective	open	and	endovascular	AAA	repair	(EVAR).		
METHODS	
Data	were	collected	prospectively	as	part	of	the	standard	multi-disciplinary	assessment	on	all	
patients	who	underwent	a	symptom	limited	maximal	exercise	CPET	prior	to	elective	AAA	repair	at	
Central	Manchester	Foundation	Trust	and	University	Hospital	of	South	Manchester	between	24th	
January	2007	and	01st	October	2012.	The	cohort	significantly	overlaps	with	a	previous	study	by	our	
group	on	CPET	and	peri-operative	mortality	following	elective	AAA	repair.15	Both	contributing	
hospitals	are	part	of	Vascular	Governance	North	West	which	has	approval	from	both	the	NRES	
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Committee	North	West	(09/H1010/2+5)	and	Section	251	approval.	As	stated	in	the	terms	of	the	
VGNW	ethical	approval,	because	this	project	involved	the	analysis	of	pseudonymous,	non-
identifiable	patient	data	specific	ethical	approval	was	not	required.		
CPET	was	performed	using	a	cycle	ergometer	and	a	ramped	test	(Wasserman)	protocol,16	with	the	
UltimaTM	CardiO2®	MedGraphics	equipment	(Medical	Graphics,	St	Paul,	Minnesota,	USA)	linked	into	
the	BreezeSuiteTM	software	package	(Medical	Graphics,	St	Paul,	Minnesota,	USA).	CPET	equipment	
was	maintained	under	manufacturer	maintenance	contracts	and	calibrated	prior	to	testing	in	
keeping	with	manufacturer	recommendations.	 All	CPET	tests	were	performed	and	interpreted	by	
appropriately	trained	consultant	anaesthetists	to	a	set	of	standardised	clinical	criteria	across	the	two	
participating	centres’	
Baseline	data	were	recorded	and	the	patient	then	cycled	for	three	minutes	with	no	resistance	at	a	
rate	of	approximately	60	revolutions	per	minute.	After	these	three	minutes	increasing	resistance	
was	applied	at	between	5	and	20	Watts	per	minute.	Each	CPET	was	performed	to	achieve	maximal	
patient	effort.	Criteria	used	to	determine	whether	maximal	effort	was	achieved	were	I)	heart	rate	>	
80%	of	predicted	peak	heart	rate,	II)	respiratory	Exchange	Ratio	>	1.15,	III)	criteria	for	ventilatory	
limitation	to	exercise	reached	(breathing	reserve	<	15%).	The	CPET	was	terminated	if	ST	depression	
of	>	2mm	on	the	exercise	ECG	was	observed,	a	cadence	of	>	40	rpm	could	not	be	maintained,	the	
patient	experienced	distressing	cardio-respiratory	or	musculoskeletal	symptoms	or	at	the	request	of	
the	patient.	Following	the	test	patients	were	monitored	until	cardio-respiratory	parameters	returned	
to	baseline	levels.	Data	for	the	following	CPET	variables	were	collected:	V! O2	at	anaerobic	threshold	
(AT)	in	ml	kg-1	min-1,	Peak	V! O2	in	ml	kg-1	min-1	and	V! E/	V! CO2.	The	following	discriminatory	
thresholds	for	these	CPET	variables	were	selected	a	priori	based	on	published	studies	shown	to	
identify	those	at	increased	risk	of	morbidity	and	death	among	patients	undergoing	major	non-
cardiac	surgery;	V! O2	at	AT	<	10.2	ml	kg-1	min-1	,17	Peak	V! O2	<	15	ml	kg-1	min-1,18	V! E/	V! CO2	at	AT	
>42.3		Absolute	patient	weight	in	kg	was	used	to	calculate	all	variables.	AT	was	determined	using	a	
combination	of	V-slope	and	ventilatory	equivalent	methods	and	recorded	in	ml	kg-1	min-1.19	V! E/	V!
CO2	was	recorded	at	AT,	or	when	AT	was	unclear,	taken	to	be	the	lowest	recorded	value	during	the	
incremental	part	of	the	exercise	test.20		
Inducible	cardiac	ischaemia	(ICI)	was	recorded	when		≥	1mm	of	ST	segment	depression	in	two	or	
more	adjacent	ECG	leads	on	the	CPET	exercise	ECG	and/or	gas	analysis	changes	consistent	with	
ischaemia	were	present.21			Reversible	ischaemia	present	on	either	stress	myoview	or	dobutamine	
stress	echocardiogram	within	five	years	of	surgery	was	also	classified	as	ICI.	Patients	continued	their	
5 
 
usual	medication	up	until	CPET	testing	and	heart	rate	limiting	medications	were	not	stopped.	Patient	
co-morbidity	data	were	collected	either	by	the	clinician	responsible	for	the	patient	or	a	clinical	audit	
team.	Preoperative	laboratory	investigations	included	haemoglobin	(anaemia	defined	as	<	13.0	g	dl-1	
for	men	and	<11.0	g	dl-1	for	women),	urea	(abnormal	defined	as	>7.5	mmol	l-1),	creatinine	(abnormal	
defined	as	>120µmol	l-1)	and	diagnosis	of	a	juxta/supra	renal	AAA	as	defined	by	the	operating	
surgeon.	The	primary	outcome	measure	was	survival	following	elective	AAA	repair.	Follow–up	data	
were	collected	using	the	NHS	Demographic	Batch	Service	on	1st	August	2013.		
Statistical	analysis	
All	variables	missing	for	more	than	15	per	cent	of	subjects	were	excluded	from	analysis.	For	
remaining	variables,	missing	data	were	imputed	with	the	median	value	for	continuous	or	categorical	
variables	and	the	baseline	value	for	dichotomous	variables.	If	AT	could	not	be	determined	from	the	
CPET	it	was	assumed	to	be	<10.2	ml	kg-1	min-1. Continuous	variables	are	reported	as	mean	±	
standard	deviation	(SD),	and	categorical	and	dichotomous	variables	reported	as	number	
(percentage).	Patient	characteristics	were	compared	between	open	AAA	repair	and	EVAR	groups	
using	the	student	t	test	for	age	and	the	χ2	test	for	dichotomous	variables.Categorical	and	
dichotomous	variables	were	examined	graphically	using	Kaplan-Meier	graphs,	and	compared	using	
the	log	rank	test.	Continuous	variables	were	assessed	by	fitting	univariate	Cox	proportional	hazards	
(PH)	regression	models.	The	functional	form	of	continuous	variables	other	than	CPET	measurements	
was	assessed	by	fitting	smoothing	curves	to	Martingale	residual	plots.			
Multivariate	Cox	PH	models	were	developed	by	including	variables	that	were	significant	at	the	P	
<0.20	level	at	univariate	analysis.	The	PH	assumption	was	formally	and	graphically	assessed	using	the	
Grambsch-Therneau	test	based	on	scaled	Schoenfeld	residuals.22	Variables	found	to	significantly	
violate	the	PH	assumption	were	used	to	stratify	the	baseline	hazards	function.	All	statistical	analyses	
were	performed	using	R	(version	3.0.1)	statistical	computing	software.23	A	P-value	<0.05	was	
considered	statistically	significant.	
RESULTS	
Patient	characteristics	and	in-hospital	mortality	
During	the	study	period	506	patients	performed	a	preoperative	CPET	and	went	on	to	have	elective	
AAA	repair.	The	median	time	between	CPET	and	surgery	was	56	days	(first	quartile	–	third	quartile	
26-90).	The	mean	age	at	operation	was	73.4	(range	44-90)	and	the	majority	(82.6%)	of	patients	were	
men.	The	majority	(327,	64.6%)	of	patients	underwent	endovascular	AAA	repair.	The	differences	in	
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patient	characteristics	between	these	groups	are	shown	in	Table	1.	Those	undergoing	EVAR	were	
more	likely	to	be	older,	have	a	history	of	IHD	and	demonstrate	limited	functional	capacity	(as	
determined	by	CPET).	Patients	who	underwent	EVAR	were	less	likely	to	have	treated	hypertension	or	
a	juxta/supra	renal	AAA	repair.	AT	could	not	be	determined	in	53	(10.5%)	patients.	The	in-hospital	
mortality	rate	was	1.86%	in	the	EVAR	group,	4.00%	in	the	open	repair	group	and	2.61%	overall.			
Survival	analysis	
The	median	follow	up	time	was	26	months	with	a	maximum	follow	up	time	of	67	months.	There	
were	90	deaths	overall	in	the	study	cohort.	Inspection	of	the	Kaplan-Meier	graph	stratified	by	open	
surgery	and	EVAR	(Figure	1)	demonstrated	that	operation	type	failed	to	satisfy	the	PH	assumption	
(Grambsch-Therneau	test	P	=	0.007)	due	to	a	crossing	in	the	curves	at	approximately	six	months.	
Therefore	the	model	was	stratified	on	this	variable.	Following	univariate	analysis,	the	following	
variables	were	significant	at	the	P	<	0.20	level:	age	(P	=	0.013),	gender	(P	=	0.157),	diabetes	(P	=	
0.035),	inducible	cardiac	ischemia	(P	=	0.147),	statins	(P	=	0.019),	creatinine	(P	<	0.001),	elevated	
urea	(P	=	0.001),	haemoglobin	(P	<	0.001)	and	the	CPET	variables,	V! E/	V! CO2	at	AT	<	42	(P	=	0.005),	
Peak	V! O2	<	15	ml	kg-1	min-1	(P	<	0.001)	and	AT	<	10.2	ml	kg-1	min-1	(P	=	0.003).	The	number	of	sub-
threshold	CPET	variables	was	an	important	risk	factor	for	reduced	survival	as	shown	in	Figure	2	(P	<	
0.001).	As	shown	in	Table	2,	patients	with	zero	or	one	sub-threshold	CPET	variables	had	a	three-year	
survival	of	86.4%	compared	to	59.9%	in	patients	with	three	sub-threshold	CPET	variables.	
A	strong	linear	relationship	between	peak	V! O2	(ml	kg-1	min-1)	and	AT	(ml	kg-1	min-1)	for	all	pairwise-
complete	records	was	demonstrated	(Pearson’s	sample	correlation	coefficient	r	=	0.81;	regression	
slope	=	0.508,	P	<	0.001)	as	shown	in	Figure	3.	As	there	is	significantly	more	missing	data	for	AT,	but	
the	relationship	between	AT	and	Peak	V! O2	is	strong,	which	would	introduce	co-linearity	into	the	
regression	modelling,	AT	was	not	included	in	the	multivariate	analyses.	The	final	model	is	shown	in	
Table	3.	Patient	characteristics	associated	with	reduced	survival	included	male	gender,	diabetes	not	
taking	pre-operative	statins,	low	haemoglobin,	V! E/	V! CO2>	42	at	AT	and	peak	V! O2	<	15	ml	kg-1	min-1.	
The	final	model	satisfied	the	assumption	of	proportional	hazards	(Grambsch-Therneau	test	P	=	
0.285).	
DISCUSSION	
This	study	demonstrates	that	variables	derived	from	pre-operative	CPET	testing	are	independent	risk	
factors	for	reduced	survival	following	elective	AAA	repair.	Patients	with	multiple	sub-threshold	CPET	
values	had	significantly	reduced	survival	compared	to	those	with	zero	or	one	abnormal	value.	PeakV!
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O2	(<	15	ml	kg-1	min-1)	and	V! E/	V! CO2	(>42)	were	independent	predictors	of	reduced	survival.	These	
results	are	applicable	to	patients	undergoing	both	open	AAA	repair	and	EVAR.	
This	is	the	largest	study	to	date	of	exploring	the	association	between	preoperative	CPET	variables	
and	survival	following	elective	AAA	repair.	It	is	also	the	first	study	to	report	that	CPET	variables	are	
associated	with	survival	in	a	cohort	of	patients	that	includes	patients	undergoing	EVAR.	Coupled	with	
the	previous	analysis	on	short-term	outcomes	following	elective	AAA	repair	conducted	by	our	group,	
each	CPET	variable	studied	has	be	shown	to	be	potentially	useful	for	predicting	outcomes	following	
elective	AAA	repair.	For	30-day	mortality	V! O2	at	AT	<	10.2	ml	kg-1	min-1	is	an	independent	predictor	
of	outcome	with	a	peak	V! O2	<	15	ml	kg-1	min-1	being	an	independent	predictor	of	90-day	mortality	
.15	For	survival	a	peak	V! O2	<	15	ml	kg-1	min-1	and	a	V! E/	V! CO2	at	AT	of	>	42	were	independent	
predictors.	An	AT	<	10.2	ml	kg-1	min-1	may	have	been	an	independent	predictor	of	reduced	survival	
but	it	was	not	examined	in	the	multivariate	analysis	due	to	co-linearity.	
AT	and	peak	V! O2	are	both	measures	of	aerobic	or	functional	capacity	and	it	is	therefore	not	
surprising	that	a	strong	linear	relationship	between	the	two	was	demonstrated.	The	association	
between	AT	and	early	mortality	has	been	demonstrated	in	series	of	patients	undergoing	major	non-
cardiac	surgery	which	have	included	some	open	AAA	repairs.7	10	17	AT	is	not	reliant	on	patient	
motivation	and	has	been	shown	to	be	a	reproducible	measure	of	aerobic	capacity	in	preoperative	
patients.26	Although	its	estimation	can	be	subjective	it	has	been	shown	to	be	reliably	interpreted	
between	different	clinicians.27	However	the	AT	may	not	be	apparent	in	all	patients.	The	approach	
adopted	for	imputing	missing	AT	data	in	this	study	was	selected	by	the	research	team	as	it	was	felt	
that	for	patients	in	whom	AT	could	not	be	determined	it	was	more	likely	to	be	sub-threshold.	This	
approach	is	a	potential	limitation	and	as	a	result	peak	V! O2		rather	than	AT	was	included	in	the	
multivariate	analysis.		
Peak	V! O2	is	simply	the	highest	V! O2	achieved	by	an	individual	during	an	exercise	test.	The	Peak	V! O2	
achieved	during	a	test	is	therefore	effort	dependent.	V! O2	max	represents	the	limit	of	functional	
capacity	for	an	individual	and	is	reached	when	there	is	a	plateauing	of	the	V! O2	response	to	exercise	
despite	an	increasing	work	rate.	V! O2	max	is	rarely	achieved	in	clinical	practice	but	when	a	maximal	
effort	CPET	is	performed	by	an	individual,	the	peak	V! O2	achieved	should	provide	a	reasonable	
reflection	of	their	V! O2	max.	In	this	study,	all	CPET	was	performed	with	the	intention	of	achieving	a	
maximal	patient	effort.	This	is	not	the	case	in	other	centres	in	the	UK	where	sub-maximal	testing	
may	be	performed.10	Given	these	results,	where	safe	and	feasible,	CPET	should	be	performed	to	a	
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maximal	effort	to	facilitate	risk	stratification.	Peak	V! O2	is	also	associated	with	increased	
perioperative	in	patients	undergoing	lung	resection	surgery.18	
An	elevated	V! E/	V! CO2	(>42)	has	previously	been	shown	to	be	an	important	predictor	of	mid-term	
mortality	in	AAA	repair.3	An	elevated	V! E/	V! CO2	is	likely	to	be	multi-factorial	in	nature	and	represent	
systemic	disease	severity.28	In	patients	with	heart	failure	abnormal	V! E/	V! CO2	has	been	significantly	
correlated	with	increased	ventilation	perfusion	mismatch,	decreased	cardiac	output,	elevated	
pulmonary	pressures,	decreased	alveolar-capillary	membrane	conductance,	and	diminished	heart	
rate	variability.29	V! E/	V! CO2	as	a	predictor	has	the	advantage	of	high	test	reliability	and	does	not	
depend	on	the	mode	of	exercise	or	testing	protocol	used.28	
Other	risk	factors	that	were	associated	with	an	increased	risk	of	reduced	survival	in	this	study	
included	low	pre-operative	haemoglobin,	not	taking	pre-operative	statins,	diabetes	and	male	
gender.	Anaemia	has	been	found	to	correlate	with	unfavourable	outcomes	in	both	surgical	and	non-
surgical	population,30	and	has	been	found	to	be	associated	with	reduced	long-term	survival	following	
EVAR.31	This	study	adds	further	evidence	to	the	existing	literature,32	33	that	statin	usage	is	associated	
with	improved	outcomes	following	AAA	repair.	Diabetes	has	previously	been	found	to	be	associated	
with	reduced	survival	in	patients	undergoing	AAA	repair.34	The	improved	survival	in	women	in	this	
study	is	unusual	and	may	be	a	reflection	of	patient	selection	practices	at	the	two	centres.			
This	study	represents	contemporary	practice	at	two	tertiary	vascular	centres	with	good	in-hospital	
mortality	rates.	CPET	was	performed	as	part	of	routine	multi-disciplinary	preoperative	assessment	
and	was	utilised	in	clinical	decision	making.	As	a	result	of	the	non-randomised,	observational	nature	
of	the	study,	there	were	significant	differences	in	the	patient	characteristics	between	the	open	AAA	
repair	and	EVAR	groups.	Patients	with	limited	functional	capacity	were	more	likely	to	undergo	EVAR	
and	those	undergoing	open	repair	were	more	likely	to	have	unfavourable	anatomy	for	EVAR.	
However	as	the	objective	of	the	study	was	not	to	compare	treatment	groups	this	is	not	a	limitation	
of	the	study.	Although	this	is	the	largest	study	to	date	of	CPET	in	AAA	repair,	the	sample	size	remains	
relatively	small	for	a	modelling	study	and	this	is	reflected	in	the	wide	confidence	intervals	produced	
on	multivariable	analysis.			
All	CPET	data	were	collected	prospectively	in	a	standardised	way	across	the	two	centres,	however,	a	
potential	limitation	of	the	study	is	that	tests	were	not	independently	reviewed	prior	to	analysis	to	
ensure	standardisation.	This	was	not	felt	to	be	necessary	by	the	research	team	due	to	the	
standardisation	of	methods	across	the	two	centres.	A	limitation	of	the	study	is	that	the	recording	of	
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ICI	differed	between	the	two	centres	with	one	deriving	ICI	exclusively	from	the	CPET	test	and	the	
other	recording	ICI	as	present	also	based	on	the	use	of	non-invasive	stress	testing.	As	a	result	ICI	was	
not	exclusively	defined	by	CPET	testing	it	has	not	been	included	as	a	CPET	variable	for	this	study.			
A	potential	limitation	of	the	analysis	approach	is	that	although	CPET	variables	are	recorded	as	
continuous	variables	they	were	dichotomised	for	this	analysis.	This	was	a	pragmatic	choice	based	on	
clinical	judgement	and	previously	published	studies,3	,17	,18	to	balance	model	fit	and	model	complexity	
given	the	relatively	small	number	of	outcomes.	Although	the	median	follow-up	time	is	relatively	
short,	three-year	survival	is	clearly	an	important	outcome	following	elective	AAA	repair	as	data	from	
randomised	controlled	trials	suggests	that	from	approximately	two	years	onwards	survival	is	the	
same	for	patients	who	undergo	open	AAA	repair	or	EVAR.24	25		
This	study	demonstrates	that	preoperative	CPET	to	maximal	effort	can	identify	patients	with	
reduced	survival	following	elective	AAA	repair	independent	of	the	type	of	repair.	These	risks	can	be	
weighed	against	the	risk	of	AAA	rupture	which	is	frequently	expressed	in	terms	of	rupture	risk	per	
year	to	facilitate	clinical	decision	making.	The	costs	of	CPET	are	relatively	low	at	approximately	£200	
per	patient	at	our	centres.	CPET	is	also	safe	with	only	a	minimal	risk	of	adverse	events.28	However,	
the	exact	value	of	its	contribution	to	pre-operative	assessment	along	with	its	cost-effectiveness	is	
still	uncertain.	Further	studies	assessing	the	utility	of	CPET	alongside	clinical	prediction	models	are	
required.		
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TABLES	
Table	1:	Differences	in	patient	characteristics	for	patients	undergoing	open	AAA	repair	and	EVAR		
Patient	Characteristic	
Overall	cohort	
n=506	(%)	
Open	repair	
n=178	(%)	
EVAR																								
n=	328	(%)	 p	value	
Missing	data	
n=506	(%)	
Age	 73.4	(44	–	90)	 70.5	(48	–	86)	 75.0	(44	–	90)	 <0.001	 0	(0.0)	
Female	 87	(17.2)	 39	(21.9)	 48	(14.7)	 0.053	 1	(0.2)	
Diabetes	 50	(9.9)	 15	(9.0)	 35	(11.9)	 0.441	 47	(9.3)	
Ischaemic	heart	disease	 214	(42.3)	 51	(31.5)	 163	(55.8)	 <0.001	 52	(10.3)	
Treated	hypertension	 178	(35.2)	 80	(46.5)	 98	(31.0)	 <0.001	 18	(3.6)	
Antiplatelet	medication	 330	(65.2)	 124	(70.1)	 206	(63.8)	 0.187	 6	(1.2)	
Statin	 324	(64.0)	 123	(69.5)	 201	(62.2)	 0.126	 6	(1.2)	
Haemoglobin	g	l-1	 13.3	±	1.8	 13.6	±	1.9	 13.2	±	1.8	 0.022	 14	(2.8)	
Urea	>7.5mmol	l-1	 7.4	±	3.3	 7.1	±	2.5	 7.6	±	3.6	 0.407	 13	(2.6)	
Creatinine	>	120µmol	l-1	 103.7	±	51.6	 99.3	±	31.8	 106.0	±	59.6	 0.099	 9	(1.8)	
Supra/juxta	renal	 59	(11.7)	 46	(26.0)	 13	(4.2)	 <0.001	 20	(4.0)	
AAA	diameter	(mm)	 63.1	±	10.1	 64.0	±	11.0	 62.5	±	9.5	 0.125	 32	(6.3)	
AT	<	10.2	ml	kg-1	min-1	 189	(37.4)	 46	(27.2)	 143	(50.3)	 <0.001	 53	(10.5)	
V! E/	V! CO2	at	AT	>42	 80	(15.8)	 17	(10.0)	 63	(19.3)	 0.006	 2	(0.4)	
Peak	V! O2	<	15	ml	kg-1	min-1	 256	(50.6)	 66	(37.1)	 190	(57.9)	 <0.001	 0	(0.0)	
ICI	 46	(9.1)	 12	(6.7)	 34	(10.5)	 0.222	 3	(0.6)	
≥2	sub-threshold	CPET	values	 213	(42.1)	 49	(27.3)	 164	(50.2)	 <0.001	 0	(0.0)	
3	sub-threshold	CPET	values	 54	(10.7)	 10	(5.6)	 44	(13.5)	 0.010	 0	(0.0)	
Continuous	data	(with	the	exception	of	age	which	is	shown	as	mean	and	range)	are	shown	as	mean	±	
standard	deviation	and	dichotomous	data	are	shown	as	number	(percentage).	p	value	calculated	
using	χ2	test	with	the	exception	of	age	which	was	calculated	using	a	student	t	test:	AAA,	abdominal	
aortic	aneurysm;	EVAR,	endovascular	aneurysm	repair;	M,	male;	F,	female;	AT,	anaerobic	threshold;	
V! E/	V! CO2,	ventilatory	equivalents	for	carbon	dioxide;	peak	V! O2,	peak	oxygen	consumption;	ICI,	
inducible	cardiac	ischaemia.	
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Table	2:	Survival	following	elective	AAA	repair	stratified	by	number	of	sub-threshold	CPET	variables	
Number	of	sub-threshold	CPET	
variables	
1	year	survival	 3	year	survival	
0-1	 94.4%	 86.4%	
2	 86.9%	 78.0%	
3	 76.7%	 59.9%	
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Table	3:	Results	of	Cox	proportional	hazards	multivariable	analysis	for	survival	after	abdominal	aortic	
aneurysm	repair.	The	baseline	hazard	function	is	stratified	on	operation	type	(open	surgery	or	
EVAR).	
	 Hazard	ratio	(95%CI)	 P	
Age	(years)	 1.008	(0.977-1.041)	 0.603	
Female	 0.436	(0.224-0.849)	 0.015	
Diabetes	 1.954	(1.035-3.687)	 0.039	
Inducible	cardiac	ischemia	 1.640	(0.901-2.986)	 0.106	
Statin	 0.583	(0.376-0.905)	 0.016	
Creatinine	(µmol	l-1)	 1.002	(0.998-1.006)	 0.278	
Urea	(mmol	l-1)	 1.066	(0.988-1.151)	 0.101	
Haemoglobin	(g	dl-1)	 0.842	(0.744-0.953)	 0.006	
V! E/	V! CO2>	42	at	AT	 1.628	(1.009-2.627)	 0.046	
Peak	VO2	<	15	(ml	kg-1	min-1)	 1.676	(1.002-2.803)	 0.049	
HR,	hazard	ratio;	CI,	confidence	interval;	AT,	anaerobic	threshold;	V! E/	V! CO2,	ventilatory	equivalents	
for	carbon	dioxide;	peak	V! O2,	peak	oxygen	consumption	
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LEGENDS	TO	ILLUSTRATIONS	
Figure	1:	Kaplan-Meier	graph	for	survival	following	elective	AAA	repair	by	procedure	type.	Survival	is	
initially	worse	in	the	open	AAA	repair	group	with	the	survival	curves	crossing	at	approximately	6	
months	and	survival	subsequently	worse	in	the	EVAR	group	(P	<	0.001,	log	rank	test).		
Figure	2:	Kaplan-Meier	graph	for	survival	following	elective	AAA	repair	by	the	number	of	sub-
threshold	CPET	values	(P	<	0.001,	log	rank	test).	
Figure	3:	Plot	of	Peak	VO2	against	AT	for	pairwise-complete	records.	Green	triangles	indicate	the	
patient	was	alive	at	the	end	of	follow-up;	blue	circles	indicate	that	death	occurred	during	follow-up.	
The	vertical	dashed	lines	on	the	bottom	axis	indicate	the	measured	Peak	VO2	for	patients	who	did	
not	have	a	recorded	AT	measurement	(coloured	as	appropriated).	The	black	dotted	line	indicates	the	
linear	model	regression	line	(Pearson’s	sample	correlation	coefficient	r	=	0.81;	regression	slope	=	
0.508	(P	<	0.001)).	The	red	lines	delineate	the	thresholds	used	to	dichotomise	sub-threshold	CPET	
values.	
	
 
